Key Highlights in interstitial lung disease: Insights from ATS 2026
Learning Objectives:
Understand the key highlights and latest advancements in ILD presented at ATS 2026.
Review and interpret the outcome and key data from ILD trials presented at ATS 2026.
Assess the clinical relevance and potential impact of these findings on patient care.
Program date: June 3, 2026
Speakers:
Dr. Jolene Fisher
M.D., FRCPC
Respirologist at the University Health Network
Research Director of the Interstitial
Lung Disease Clinic Toronto General Hospital
Moderator:
Dr. Leigh Minuk
M.D., FRCPC
Respirologist, Centre for Lung Health,
Vancouver General Hospital
Questions?
The presenters are solely responsible for developing the content of this presentation and maintaining scientific accuracy, objectivity, and balance. Any discussions of clinical practice or treatment represent the opinions of the presenter alone. This video is made available for attendees, registrants, and individuals requesting further information on this learning program.